Your browser doesn't support javascript.
loading
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions.
Roche, Stephanie D; Were, Daniel; Crawford, Natalie D; Tembo, Angela; Pintye, Jillian; Bukusi, Elizabeth; Ngure, Kenneth; Ortblad, Katrina F.
Afiliación
  • Roche SD; Public Health Sciences Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. sroche@fredhutch.org.
  • Were D; Jhpiego, Nairobi, Kenya.
  • Crawford ND; Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Tembo A; Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Pintye J; School of Nursing, University of Washington, Seattle, USA.
  • Bukusi E; Department of Global Health, University of Washington, Seattle, USA.
  • Ngure K; Department of Global Health, University of Washington, Seattle, USA.
  • Ortblad KF; Department of Obstetrics and Gynecology, University of Washington, Seattle, USA.
Curr HIV/AIDS Rep ; 21(3): 116-130, 2024 06.
Article en En | MEDLINE | ID: mdl-38517671
ABSTRACT
PURPOSE OF REVIEW To provide an overview of the current state of HIV pre-exposure prophylaxis (PrEP) delivery via private sector pharmacies globally, to discuss the context-specific factors that have influenced the design and implementation of different pharmacy-based PrEP delivery models in three example settings, and to identify future research directions. RECENT

FINDINGS:

Multiple high- and low-income countries are implementing or pilot testing PrEP delivery via private pharmacies using a variety of delivery models, tailored to the context. Current evidence indicates that pharmacy-based PrEP services are in demand and generally acceptable to clients and pharmacy providers. Additionally, the evidence suggests that with proper training and oversight, pharmacy providers are capable of safely initiating and managing clients on PrEP. The delivery of PrEP services at private pharmacies also achieves similar levels of PrEP initiation and continuation as traditional health clinics, but additionally reach individuals underserved by such clinics (e.g., young men; minorities), making pharmacies well-positioned to increase overall PrEP coverage. Implementation of pharmacy-based PrEP services will look different in each context and depend not only on the state of the private pharmacy sector, but also on the extent to which key needs related to governance, financing, and regulation are addressed. Private pharmacies are a promising delivery channel for PrEP in diverse settings. Countries with robust private pharmacy sectors and populations at HIV risk should focus on aligning key areas related to governance, financing, and regulation that have proven critical to pharmacy-based PrEP delivery while pursuing an ambitious research agenda to generate information for decision-making. Additionally, the nascency of pharmacy-based PrEP delivery in both high- and low-and-middle-income settings presents a prime opportunity for shared learning and innovation.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Humans Idioma: En Revista: AIDS Rep Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Humans Idioma: En Revista: AIDS Rep Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos